Pekin Hardy Strauss, Inc. Roivant Sciences Ltd. Transaction History
Pekin Hardy Strauss, Inc.
- $749 Million
- Q3 2024
A detailed history of Pekin Hardy Strauss, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 53,350 shares of ROIV stock, worth $645,535. This represents 0.08% of its overall portfolio holdings.
Number of Shares
53,350
Previous 54,050
1.3%
Holding current value
$645,535
Previous $571,000
7.71%
% of portfolio
0.08%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$798 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$796 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$655 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$504 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$428 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.52B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...